FMO5 and endothelial dysfunction: Since earlier report has shown that diabetes-induced endothelial dysfunction was caused by increased ROS [5], there would be 2 possibilities as the underlying mechanisms of endothelial protective effect; Nicorandil could inhibit both the expression and activity of NADPH oxidase, a major source of ROS [23,24], leading to the reduction of ROS production.